(Q73012258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

editorial

0 references

title

Estimating the importance of infection in IBS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

238-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

One-year follow-up of newly diagnosed irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07275.X

10.1111/J.1572-0241.2003.07275.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12591034%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference